DMPI - DelMar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 517.5M
Enterprise Value 35.43M
Trailing P/E N/A
Forward P/E 1-3.12
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.81
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-57.94%
Return on Equity (ttm)-100.13%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-8.98M
Diluted EPS (ttm)-0.6890
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.16M
Total Cash Per Share (mrq)0.61
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.45
Book Value Per Share (mrq)0.29

Cash Flow Statement

Operating Cash Flow (ttm)-8.78M
Levered Free Cash Flow (ttm)-5.38M

Trading Information

Stock Price History

Beta 1.52
52-Week Change 3-78.59%
S&P500 52-Week Change 318.18%
52 Week High 35.3900
52 Week Low 30.7800
50-Day Moving Average 30.8693
200-Day Moving Average 31.3935

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 3311.38k
Shares Outstanding 521.6M
Float 16.96M
% Held by Insiders 111.56%
% Held by Institutions 116.87%
Shares Short 31.25M
Short Ratio 32.21
Short % of Float 36.27%
Shares Short (prior month) 31.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A